3 research outputs found
Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia
A study of children was conducted in 3 Central Asian Republics. Approximately half of the Streptococcus pneumoniae isolates were serotypes included in available vaccine formulations. Approximately 6% of children carried Haemophilus influenzae type b (Hib). Using pneumococcal and Hib conjugate vaccines may decrease illness in the Central Asian Republics
ASSOCIATION OF GENETIC POLYMORPHISMS WITH COMPLICATIONS OF IMPLANTED LVAD DEVICES IN PATIENTS WITH CONGESTIVE HEART FAILURE: A KAZAKHSTANI STUDY
The left ventricular assist device (LVAD) is one of the alternative treatments for heart failure
(HF) patients. However, LVAD support is followed by thrombosis, and bleeding complications which
are caused by high non-physiologic shear stress and antithrombotic/anticoagulant therapy. A high
risk of complications occurs in the presence of the genotype polymorphisms which are involved in the
coagulation system, hemostasis function and in the metabolism of the therapy. The aim of the study
was to investigate the influence of single-nucleotide polymorphisms (SNP) in HF patients with LVAD
complications. We analyzed 21 SNPs in HF patients (n = 98) with/without complications, and healthy
controls (n = 95). SNPs rs9934438; rs9923231 in VKORC1, rs5918 in ITGB3 and rs2070959 in UGT1A6
demonstrated significant association with HF patients’ complications (OR (95% CI): 3.96 (1.42–11.02),
p = 0.0057), (OR (95% CI): 3.55 (1.28–9.86), p = 0.011), (OR (95% CI): 5.37 (1.79–16.16), p = 0.0056)
and OR (95% CI): 4.40 (1.06–18.20), p = 0.044]. Genotype polymorphisms could help to predict
complications at pre- and post-LVAD implantation period, which will reduce mortality rate. Our
research showed that patients can receive treatment with warfarin and aspirin with a personalized
dosage and LVAD complications can be predicted by reference to their genotype polymorphisms in
VKORC1, ITGB3 and UGT1A6 genes
Epidemiology and distribution of interstitial lung diseases in Turkey
Introduction: There is very few data on the epidemiological features of interstitial lung diseases (ILD) in the literature. These studies on this subject suffer from limited number of patients. Objective: The goal of this study was to evaluate the epidemiological features of ILD in Turkey. Methods: Fifty-four investigators, 31 centres in 19 cities from six regions of Turkey, participated in the study. Two thousand two hundred forty-five newly diagnosed patients (51.8% females), led by Turkish Thoracic Society Clinical Problems Study Group, enrolled in this prospective study. Results: The mean age was 51.8±16.7 years. The mean age among males was 50.5±18.6 years and 53.0±14.6 years among females (P<0.001). 23.8% of the cases had ILD with known causes, while 39.4% were in granulomatous group, 23.7% were idiopathic, and 4.4% were in the unclassified group. Overall, histopathologically confirmed diagnosis rate was 40.4%. Sarcoidosis was the most common disease (37%), whereas cases with idiopathic pulmonary fibrosis (IPF) constituted 19,9% of patients. 53% of the sarcoidosis patients were females, and the ratio reaches to 75% under 50 years of age (for this group, IPF ratio is %3). In contrast, sarcoidosis and IPF ratios were equal in males (25%). Sarcoidosis was 8% in men over 50, while IPF was %45. Conclusion: The overall incidence of ILD in Turkey was computed to be 25.8/100000. © 2013 John Wiley & Sons Ltd